S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
AI medical stock landing MASSIVE contracts (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
AI medical stock landing MASSIVE contracts (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
AI medical stock landing MASSIVE contracts (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
AI medical stock landing MASSIVE contracts (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
AI medical stock landing MASSIVE contracts (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
AI medical stock landing MASSIVE contracts (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Has the Fed lost control of the banking system? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
AI medical stock landing MASSIVE contracts (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
AI medical stock landing MASSIVE contracts (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

MyHealthChecked (MHC) Competitors

GBX 14.41
+0.91 (+6.75%)
(As of 05:37 AM ET)

MHC vs. RUA, SUN, DEMG, POLX, IHC, TRLS, VAL, GDR, CNSL, and GENI

Should you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Trellus Health (TRLS), ValiRx (VAL), genedrive (GDR), Cambridge Nutritional Sciences (CNSL), and GENinCode (GENI). These companies are all part of the "medical" sector.

MyHealthChecked vs.

RUA Life Sciences (LON:RUA) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

RUA Life Sciences and MyHealthChecked both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
RUA Life SciencesOutperform Votes
No Votes
Underperform Votes
6
100.00%
MyHealthCheckedN/AN/A

MyHealthChecked has a net margin of 1.26% compared to MyHealthChecked's net margin of -100.05%. RUA Life Sciences' return on equity of 2.22% beat MyHealthChecked's return on equity.

Company Net Margins Return on Equity Return on Assets
RUA Life Sciences-100.05% -40.56% -27.86%
MyHealthChecked 1.26%2.22%6.38%

RUA Life Sciences has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.

In the previous week, RUA Life Sciences had 1 more articles in the media than MyHealthChecked. MarketBeat recorded 1 mentions for RUA Life Sciences and 0 mentions for MyHealthChecked. MyHealthChecked's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.

Company Overall Sentiment
RUA Life Sciences Neutral
MyHealthChecked Neutral

19.6% of RUA Life Sciences shares are owned by institutional investors. Comparatively, 3.1% of MyHealthChecked shares are owned by institutional investors. 19.6% of RUA Life Sciences shares are owned by insiders. Comparatively, 38.6% of MyHealthChecked shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

MyHealthChecked has higher revenue and earnings than RUA Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RUA Life Sciences£1.87M3.42-£1.87M-£0.08-129.00
MyHealthChecked£14.95M0.50£1.52MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RUA Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
MyHealthChecked
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

MyHealthChecked beats RUA Life Sciences on 8 of the 11 factors compared between the two stocks.


Get MyHealthChecked News Delivered to You Automatically

Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MHC vs. The Competition

MetricMyHealthCheckedMedical Devices IndustryMedical SectorLON Exchange
Market Cap£7.50M£2.10B£4.98B£1.34B
Dividend YieldN/A2.35%2.91%12.11%
P/E Ratio316.67198.8295.431,577.32
Price / Sales0.50308.372,942.70420,568.66
Price / Cash1.7819.2487.6332.82
Price / Book0.904.404.242.50
Net Income£1.52M£51.64M£112.29M£187.83M
7 Day Performance13.03%-1.53%0.47%-0.03%
1 Month Performance20.09%-1.42%6.40%0.56%
1 Year Performance860.73%-0.89%7.55%6.15%

MyHealthChecked Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RUA
RUA Life Sciences
0 of 5 stars
GBX 10.75
+2.4%
N/A-83.2%£6.67M£1.87M-134.3848News Coverage
SUN
Surgical Innovations Group
0 of 5 stars
GBX 0.65
flat
N/A-62.8%£6.06M£11.58M-21.11100Gap Down
DEMG
Deltex Medical Group
0 of 5 stars
GBX 0.15
flat
N/A-88.1%£2.76M£2.38M-5.7544Gap Down
POLX
Polarean Imaging
0 of 5 stars
GBX 6.25
+8.7%
N/A-81.2%£13.49M£1.03M-125.0028Gap Up
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 37.30
-1.8%
N/A-38.4%£25.45M£41.08M-3,730.00210
TRLS
Trellus Health
0 of 5 stars
GBX 4.05
-4.7%
N/A-50.0%£6.54M£35,000.00405.0031Gap Down
VAL
ValiRx
0 of 5 stars
GBX 4.85
+2.1%
N/A-51.7%£6.42MN/A-161.678
GDR
genedrive
0 of 5 stars
GBX 4.88
-2.4%
N/A-83.8%£6.36M£49,000.00-81.2543
CNSL
Cambridge Nutritional Sciences
0 of 5 stars
GBX 2.55
-5.6%
N/AN/A£6.06M£9.05M-254.8091
GENI
GENinCode
0 of 5 stars
GBX 4.15
flat
N/A-81.5%£7.34M£1.72M-69.1734

Related Companies and Tools

This page (LON:MHC) was last updated on 2/23/2024 by MarketBeat.com Staff